Billings P C, St Clair W, Ryan C A, Kennedy A R
Carcinogenesis. 1987 Jun;8(6):809-12. doi: 10.1093/carcin/8.6.809.
In this report, we have investigated whether a protease inhibitor obtained from potatoes (chymotrypsin inhibitor 1; CI-1) will inhibit carcinogen-induced transformation of C3H/10T1/2 cells. CI-1 was as effective as the soybean-derived Bowman Birk inhibitor at suppressing radiation-induced transformation of C3H/10T1/2 cells, at a concentration of 10 micrograms/ml. The inhibitor was not toxic to the cells at concentrations of 0.1-10 micrograms/ml, the concentrations of CI-1 employed in the transformation experiments. To investigate the interaction of this inhibitor with the target cells, binding studies were carried out. 125I-labelled CI-1 could not be displaced from C3H/10T1/2 cells by co-incubation of the cells with a 5000-fold excess of unlabelled inhibitor. These results suggest that this inhibitor does not reversibly bind to specific receptor proteins on the surface of these cells.
在本报告中,我们研究了从土豆中获得的一种蛋白酶抑制剂(胰凝乳蛋白酶抑制剂1;CI - 1)是否会抑制致癌物诱导的C3H/10T1/2细胞转化。在浓度为10微克/毫升时,CI - 1在抑制辐射诱导的C3H/10T1/2细胞转化方面与大豆来源的鲍曼 - 伯克抑制剂效果相当。在转化实验中所使用的CI - 1浓度为0.1 - 10微克/毫升时,该抑制剂对细胞无毒。为了研究这种抑制剂与靶细胞的相互作用,我们进行了结合研究。通过将细胞与过量5000倍的未标记抑制剂共同孵育,无法从C3H/10T1/2细胞中置换出125I标记的CI - 1。这些结果表明,这种抑制剂不会与这些细胞表面的特定受体蛋白可逆性结合。